A practical view of fine-mapping and gene prioritization in the post-genome-wide association era

Autor: Broekema, R. V., Bakker, O. B., Jonkers, I. H.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Multifactorial Inheritance
Genome-wide association study
Review
Review Article
VARIANTS
DISEASE
TRANSCRIPTIONAL VARIATION
0302 clinical medicine
polygenic diseases
single-nucleotide polymorphisms
GWAS
CRISPR
lcsh:QH301-705.5
SNPS
0303 health sciences
education.field_of_study
General Neuroscience
Chromosome Mapping
Phenotype
fine-mapping
Identification (biology)
EXPRESSION
Quantitative Trait Loci
Immunology
Population
Single-nucleotide polymorphism
Computational biology
Biology
Polymorphism
Single Nucleotide

General Biochemistry
Genetics and Molecular Biology

complex traits
03 medical and health sciences
SINGLE-CELL
Quantitative Trait
Heritable

Humans
Genetic Predisposition to Disease
education
Alleles
030304 developmental biology
Genetic association
genome-wide association study
RISK PREDICTION
IDENTIFICATION
Cas9
Genetic Variation
Epistasis
Genetic

Genetics
Population

Gene Expression Regulation
Genes
lcsh:Biology (General)
Expression quantitative trait loci
causal variants and genes
030217 neurology & neurosurgery
RESPONSES
Zdroj: Open Biology, Vol 10, Iss 1 (2020)
Open Biology
ISSN: 2046-2441
DOI: 10.1098/rsob.190221
Popis: Over the past 15 years, genome-wide association studies (GWASs) have enabled the systematic identification of genetic loci associated with traits and diseases. However, due to resolution issues and methodological limitations, the true causal variants and genes associated with traits remain difficult to identify. In this post-GWAS era, many biological and computational fine-mapping approaches now aim to solve these issues. Here, we review fine-mapping and gene prioritization approaches that, when combined, will improve the understanding of the underlying mechanisms of complex traits and diseases. Fine-mapping of genetic variants has become increasingly sophisticated: initially, variants were simply overlapped with functional elements, but now the impact of variants on regulatory activity and direct variant-gene 3D interactions can be identified. Moreover, gene manipulation by CRISPR/Cas9, the identification of expression quantitative trait loci and the use of co-expression networks have all increased our understanding of the genes and pathways affected by GWAS loci. However, despite this progress, limitations including the lack of cell-type- and disease-specific data and the ever-increasing complexity of polygenic models of traits pose serious challenges. Indeed, the combination of fine-mapping and gene prioritization by statistical, functional and population-based strategies will be necessary to truly understand how GWAS loci contribute to complex traits and diseases.
Databáze: OpenAIRE